- Disease: Post-COVID-19
- Study type: Observational Cohort Study
- Study type descriptors: Interventional
- Study aim: To evaluate the impact of plitidepsin treatment on reducing viral load and accelerating patient recovery following SARS-CoV-2 infection. To assess whether this treatment could have a relevant impact on the emergence of long-term sequelae resulting from the infection
- Number of participants enrolled: 34
- Study enrolling from to
Study Data
- Adults
- Elderly
- General population
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Plitidepsin
- Antivirals
External Links
Other information
Funders:
- PharmaMar
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to